Hongxia Jia

686 total citations
34 papers, 419 citations indexed

About

Hongxia Jia is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Hongxia Jia has authored 34 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Hongxia Jia's work include Chronic Kidney Disease and Diabetes (3 papers), Peptidase Inhibition and Analysis (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Hongxia Jia is often cited by papers focused on Chronic Kidney Disease and Diabetes (3 papers), Peptidase Inhibition and Analysis (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Hongxia Jia collaborates with scholars based in China, United States and Australia. Hongxia Jia's co-authors include Lili Yu, Yanling He, Qiuhe Ji, Zhaoshun Jiang, Feifei Fan, Wang Ma, Liu Hong, Yidi Wang, Yue Zhou and Xin Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hongxia Jia

28 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongxia Jia China 12 92 74 70 62 58 34 419
Søren Andreas Just Denmark 12 74 0.8× 84 1.1× 47 0.7× 38 0.6× 12 0.2× 39 443
Jun Hong China 13 121 1.3× 48 0.6× 37 0.5× 51 0.8× 28 0.5× 16 384
Dominik Soll Germany 8 59 0.6× 27 0.4× 30 0.4× 51 0.8× 29 0.5× 16 349
Rafael Parra‐Medina Colombia 11 102 1.1× 96 1.3× 76 1.1× 27 0.4× 101 1.7× 82 436
H. Nüßlein Germany 16 72 0.8× 45 0.6× 26 0.4× 98 1.6× 37 0.6× 62 750
Cho‐Hao Lee Taiwan 13 47 0.5× 99 1.3× 43 0.6× 100 1.6× 47 0.8× 55 460
Yoon Seok Choi South Korea 14 129 1.4× 133 1.8× 77 1.1× 52 0.8× 163 2.8× 68 821
Νικόλαος Τράκας Greece 18 168 1.8× 84 1.1× 199 2.8× 73 1.2× 75 1.3× 94 846
Kyung Jin Seo South Korea 14 111 1.2× 94 1.3× 34 0.5× 54 0.9× 182 3.1× 77 656

Countries citing papers authored by Hongxia Jia

Since Specialization
Citations

This map shows the geographic impact of Hongxia Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Jia more than expected).

Fields of papers citing papers by Hongxia Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxia Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Jia. The network helps show where Hongxia Jia may publish in the future.

Co-authorship network of co-authors of Hongxia Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxia Jia. A scholar is included among the top collaborators of Hongxia Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxia Jia. Hongxia Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shanbhag, Niraj M., Jaya Padmanabhan, Zheng Zhang, et al.. (2025). An Acetylcholine M1 Receptor–Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment. JAMA Neurology. 82(2). 152–152. 5 indexed citations
2.
Fan, Bin, Ghassan K. Abou‐Alfa, Andrew X. Zhu, et al.. (2024). Pharmacokinetics/pharmacodynamics of ivosidenib in advanced IDH1-mutant cholangiocarcinoma: findings from the phase III ClarIDHy study. Cancer Chemotherapy and Pharmacology. 93(5). 471–479. 4 indexed citations
3.
Wang, Xinjuan, Hongping Liu, Hongxia Jia, et al.. (2024). Precision patient selection for improved detection of circulating genetically abnormal cells in pulmonary nodules. Scientific Reports. 14(1). 22532–22532. 1 indexed citations
4.
Chen, Jiaqi, Linna Li, Hongxia Jia, et al.. (2024). Association between dietary protein intake and mortality among patients with diabetic kidney disease. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 18(7). 103091–103091.
5.
Chen, Jiaqi, Linna Li, Hongxia Jia, et al.. (2024). Association of dietary iron intake with diabetic kidney disease among individuals with diabetes. Endocrine. 85(3). 1154–1161.
6.
Wu, Wenjuan, Hongxia Jia, Xinran Ma, et al.. (2024). Inhibition of OGG1 ameliorates pulmonary fibrosis via preventing M2 macrophage polarization and activating PINK1-mediated mitophagy. Molecular Medicine. 30(1). 72–72. 9 indexed citations
7.
Wang, Yan, et al.. (2023). Transcriptomic profiling and longitudinal study reveal the relationship of anti-MDA5 titer and type I IFN signature in MDA5+ dermatomyositis. Frontiers in Immunology. 14. 1249844–1249844. 6 indexed citations
8.
Jia, Hongxia, et al.. (2023). Maculopapular Drug Eruption Caused by Finasteride: A Case Report. Clinical Cosmetic and Investigational Dermatology. Volume 16. 3359–3361. 1 indexed citations
9.
Jia, Hongxia, Hongping Liu, Yan Wang, et al.. (2023). Diagnostic efficacy of metagenomic next generation sequencing in bronchoalveolar lavage fluid for proven invasive pulmonary aspergillosis. Frontiers in Cellular and Infection Microbiology. 13. 1223576–1223576. 15 indexed citations
10.
Qiu, Lingxiao, Pan Song, Huaqi Wang, et al.. (2021). Clinical Characteristics and Prognosis of Patients With Pulmonary Mucoepidermoid Carcinoma: A SEER-Based Analysis. Frontiers in Oncology. 11. 601185–601185. 11 indexed citations
11.
Wang, Huaqi, Yunfei Wang, Chunya Lu, et al.. (2021). The efficacy of probiotics in patients with severe COVID-19. Annals of Palliative Medicine. 10(12). 12374–12380. 22 indexed citations
12.
Jia, Hongxia, et al.. (2020). UAV security situation awareness method based on semantic analysis. 272–276. 8 indexed citations
13.
Jia, Hongxia & Yanling He. (2019). Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial. Journal of Dermatological Treatment. 31(8). 831–838. 17 indexed citations
15.
Cheng, Yu, et al.. (2016). [Treatment of Guishen Zhiyang Recipe for Senile Pruritus Patients with Blood Deficiency and Hy- peractivity of Gan-yang Syndrome].. PubMed. 36(12). 1460–1464.
16.
Jiang, Zhaoshun, Suxia Wang, Hongxia Jia, Jing Wang, & Yuantao Liu. (2012). Association of Toll-Like Receptor 4 Polymorphisms with Type 2 Diabetes Mellitus. Inflammation. 36(1). 251–257. 24 indexed citations
17.
Gao, Bin, Jie Zhou, Jiapu Ge, et al.. (2012). Association of Maximum Weight with Hyperuricemia Risk: A Retrospective Study of 21,414 Chinese People. PLoS ONE. 7(11). e51186–e51186. 17 indexed citations
19.
Jia, Hongxia, et al.. (2012). Associations of adiponectin gene polymorphisms with polycystic ovary syndrome: a meta-analysis. Endocrine. 42(2). 299–306. 18 indexed citations
20.
Jia, Hongxia, Lili Yu, Zhiwei Jiang, & Qiuhe Ji. (2011). Association Between IGF2BP2 rs4402960 Polymorphism and Risk of Type 2 Diabetes Mellitus: A Meta-analysis. Archives of Medical Research. 42(5). 361–367. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026